DexCom (DXCM) Tops Q3 EPS by 4c

DexCom (NASDAQ: DXCM) reported Q3 EPS of $0.28, $0.04 better than the analyst estimate of $0.24. Revenue for the quarter came in at $769.6 million versus the consensus estimate of $751.74 million.

GUIDANCE:

DexCom sees Q4 2022 revenue of $2.88-2.91 billion, versus the consensus of $2.89 billion.

For earnings history and earnings-related data on DexCom (DXCM) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank
• RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform